Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

7.0K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
7.0K
Menopause01:28

Menopause

5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

60
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
60
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

1.9K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.9K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

7.2K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
7.2K
Ovarian Cycle01:27

Ovarian Cycle

4.7K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and methods of the Third Australian Study of Health and Relationships (ASHR3): a nationally representative sexual and reproductive health survey.

Sexual health·2026
Same author

Cervical Cancer Elimination in Australia and the Asia Pacific: Progress and Barriers.

The Medical journal of Australia·2026
Same author

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

'Give People More Time and Take the Time to Explain Things Properly': Cervical Screening Experiences of People With Intellectual Disability.

Journal of applied research in intellectual disabilities : JARID·2026
Same author

Long-acting reversible contraception and medication abortion: a national descriptive survey of Australian community pharmacist knowledge, attitudes and practices.

International journal of clinical pharmacy·2026
Same author

How would Australian women and people with a cervix like to access self-collection for cervical screening? Screening preferences from a national survey.

Cancer causes & control : CCC·2026
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.8K

Perimenopausal contraception: A practice-based approach.

Deborah Bateson1, Kathleen McNamee

  • 1MBBS, MSc, MA, is Senior Medical Coordinator, Family Planning New South Wales.

Australian Family Physician
|June 14, 2017
PubMed
Summary
This summary is machine-generated.

Perimenopausal women can still become pregnant and need safe contraception. Long-acting reversible contraceptives (LARCs) are recommended, and stopping contraception after menopause requires careful consideration of age and follicle-stimulating hormone (FSH) levels.

More Related Videos

Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
03:30

Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy

Published on: October 25, 2024

2.6K
Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

5.1K

Related Experiment Videos

Last Updated: Feb 28, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.8K
Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
03:30

Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy

Published on: October 25, 2024

2.6K
Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

5.1K

Area of Science:

  • Reproductive endocrinology
  • Gynecology
  • Family planning

Background:

  • Perimenopausal women face unintended pregnancy risks despite declining fertility.
  • Comorbidities can restrict contraceptive options, necessitating guidance like the UK Medical Eligibility Criteria (UKMEC).

Purpose of the Study:

  • To offer evidence-based advice on contraceptive choices for perimenopausal women.
  • To guide decisions regarding the cessation of contraception at menopause.

Main Methods:

  • Review of current medical literature and clinical guidelines.
  • Application of the UK Medical Eligibility Criteria (UKMEC) for safe prescribing.
  • Consideration of factors influencing contraceptive choice and cessation.

Main Results:

  • Long-acting reversible contraceptives (LARCs) are effective, safe, and acceptable for many women.
  • Contraceptive decisions involve medical eligibility, side effects, non-contraceptive benefits, cost, and personal preference.
  • For women aged ≥50 using non-hormonal methods, contraception cessation is advised after 12 months of amenorrhea (or 24 months if aged 50).

Conclusions:

  • Follicle-stimulating hormone (FSH) levels can aid in determining menopause status, as amenorrhea is unreliable in this age group.
  • Personalized contraceptive strategies are essential, balancing efficacy, safety, and individual needs.
  • Informed decision-making supports safe and effective contraception management throughout perimenopause and menopause transition.